Daniel Trencher - Dec 10, 2021 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: SVP Corporate Strategy
Signature: /s/ Adam C. Vandervoort, attorney-in-fact
Stock symbol: TDOC
Transactions as of: Dec 10, 2021
Transactions value $: -$146,940
Form type: 4
Date filed: 12/13/2021, 03:10 PM
Previous filing: Nov 12, 2021
Next filing: Jan 11, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise	$44.6K	+2K	+8.52%	$22.30	25.5K	Dec 10, 2021	Direct	F1
transaction	TDOC	Common Stock	Sale	-$192K	-2K	-7.85%	$95.77	23.5K	Dec 10, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Employee Stock Option (right to buy)	Options Exercise	$0	-2K	-11.47%	$0.00	15.4K	Dec 10, 2021	Common Stock	2K	$22.30	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 28, 2020.
F2	The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vested in 36 equal monthly installments thereafter.